Emerging Medications and Strategies in Acute Pain Management: Evolving Role of Novel Sodium and Calcium Channel Blockers, Peptide-Based Pharmacologic Drugs, and Non-Medicinal Methods

被引:4
作者
Kaye, Alan D. [1 ]
Greene, Driskell R. [2 ]
Nguyen, Catherine [3 ]
Ragland, Amanda [2 ]
Granger, Mason P. [2 ]
Wilhite, William Peyton [2 ]
Dufrene, Kylie [2 ]
Shekoohi, Sahar [4 ]
Robinson, Christopher L. [5 ]
机构
[1] Louisiana State Univ, Dept Anesthesiol, Dept Pharmacol Toxicol & Neurosci, Hlth Sci Ctr, Shreveport, LA 71103 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Shreveport, LA 71103 USA
[3] Louisiana State Univ, Hlth Sci Ctr, Sch Med, 2020 Gravier St, New Orleans, LA 70112 USA
[4] Louisiana State Univ, Hlth Sci Ctr, Dept Anesthesiol, 1501 Kings Highway, Shreveport, LA 71103 USA
[5] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02215 USA
关键词
Novel medication; Acute pain management; Sodium channel; Calcium channel; Opioids; Na(v)s; VX-548; N-100; Ca(v)2.2; PREGABALIN; ZICONOTIDE; NA(V)1.7; TARGET;
D O I
10.1007/s11916-024-01265-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of Review The present investigation evaluated integration of novel medication technology to enhance treatment options, while improving patient outcomes in acute pain management. In this regard, we focused on determining the role of development and utilization of cutting-edge pharmaceutical advancements, such as targeted drug delivery systems, as well as non-pharmacologic interventions in addressing acute pain states. Further research in this area is warranted related to the need for increased patient comfort and reduced adverse effects. Recent Findings Recent innovations and techniques are discussed including pharmacologic drugs targeting sodium and calcium channels, peptide-based pharmacologic drugs, and non-medicinal methods of alleviating pain such as soothing music or virtual reality. Summary The present investigation included review of current literature on the application of these innovative technologies, analyzing mechanisms of action, pharmacokinetics, and clinical effectiveness. Our study also investigated the potential benefits in terms of pain relief, reduced side effects, and improved patient adherence. The research critically examines the challenges and considerations associated with implementing these technologies in acute pain management, considering factors like cost, accessibility, and regulatory aspects. Additionally, case studies and clinical trials are highlighted which demonstrate practical implications of these novel medication technologies in real-world scenarios. The findings aim to provide healthcare professionals with a comprehensive understanding of the evolving landscape in acute pain management while guiding future research and clinical practices toward optimizing their use in enhancing patient care.
引用
收藏
页码:853 / 862
页数:10
相关论文
共 44 条
[1]   Mechanisms of conotoxin inhibition of N-type (Cav2.2) calcium channels [J].
Adams, David J. ;
Berecki, Geza .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2013, 1828 (07) :1619-1628
[2]   Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (CaV2.2) calcium channels [J].
Adams, David J. ;
Callaghan, Brid ;
Berecki, Geza .
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (02) :486-500
[3]   Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release [J].
Alexandrou, Aristos J. ;
Brown, Adam R. ;
Chapman, Mark L. ;
Estacion, Mark ;
Turner, Jamie ;
Mis, Malgorzata A. ;
Wilbrey, Anna ;
Payne, Elizabeth C. ;
Gutteridge, Alex ;
Cox, Peter J. ;
Doyle, Rachel ;
Printzenhoff, David ;
Lin, Zhixin ;
Marron, Brian E. ;
West, Christopher ;
Swain, Nigel A. ;
Storer, R. Ian ;
Stupple, Paul A. ;
Castle, Neil A. ;
Hounshell, James A. ;
Rivara, Mirko ;
Randall, Andrew ;
Dib-Hajj, Sulayman D. ;
Krafte, Douglas ;
Waxman, Stephen G. ;
Patel, Manoj K. ;
Butt, Richard P. ;
Stevens, Edward B. .
PLOS ONE, 2016, 11 (04)
[4]   Preclinical characterization of the efficacy and safety of biologic N-001 as a novel pain analgesic for post-operative acute pain treatment [J].
Allen, Derek ;
Hanumantharao, Samerender Nagam ;
McDonell, Rylie ;
Irvine, Karen-Amanda ;
Sahbaie, Peyman ;
Clark, David ;
Blum, Paul .
SCIENTIFIC REPORTS, 2023, 13 (01)
[5]  
[Anonymous], 2021, PROTEIN ENG CHRONIC
[6]   Current Drug Development Overview: Targeting Voltage-Gated Calcium Channels for the Treatment of Pain [J].
Antunes, Flavia Tasmin Techera ;
Campos, Maria Martha ;
Ricardo Carvalho, Vanice de Paula ;
da Silva Junior, Claudio Antonio ;
Magno, Luiz Alexandre Viana ;
de Souza, Alessandra Hubner ;
Gomez, Marcus Vinicius .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
[7]   Recent advances in pain management based on nanoparticle technologies [J].
Babaie, Soraya ;
Taghvimi, Arezou ;
Hong, Joo-Hyun ;
Hamishehkar, Hamed ;
An, Seongpil ;
Kim, Ki Hyun .
JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
[8]  
Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5
[9]   Mini-review - Sodium channels and beyond in peripheral nerve disease: Modulation by cytokines and their effector protein kinases [J].
Cheng, Xiaoyang ;
Choi, Jin-Sung ;
Waxman, Stephen G. ;
Dib-Hajj, Sulayman D. .
NEUROSCIENCE LETTERS, 2021, 741
[10]  
Choudhary S., 2023, Explor. Med, V4, P85, DOI [10.37349/emed.2023.00126, DOI 10.37349/EMED.2023.00126]